{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:11:20Z","timestamp":1789499480414,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To test the hypothesis that admission hemoglobin levels are associated with outcome in primary, nontraumatic intracerebral hemorrhage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Individual patient data meta-analysis of three studies of intracerebral hemorrhage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Two randomized clinical trials and one multiethnic observational study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients with spontaneous, nontraumatic intracerebral hemorrhage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Our exposure of interest was admission hemoglobin levels and the primary outcome was 3-month postintracerebral hemorrhage-dichotomized modified Rankin Scale (0\u20133 vs 4\u20136). Intermediate outcomes were admission hematoma volume and hematoma expansion defined as 6\u2009mL or 33% increase in hemorrhage size on repeat CT. A total of 4,172 intracerebral hemorrhage patients were included in the study (mean age 63 [<jats:sc>sd<\/jats:sc> = 14]; female sex 1,668 [40%]). Each additional g\/dL of admission hemoglobin was associated with 14% (odds ratio, 0.86; 95% CI, 0.82\u20130.91) and 7% (odds ratio, 0.93; 95% CI, 0.88\u20130.98) reductions in the risk of poor outcome in unadjusted and adjusted analyses, respectively. Dose-response analyses indicated a linear relationship between admission hemoglobin levels and poor outcome across the entire evaluated range (test-for-trend <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). No consistent associations were found between the admission hemoglobin levels and hematoma volume or hematoma expansion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Higher hemoglobin levels are associated with better outcome in intracerebral hemorrhage. Further research is needed to evaluate admission hemoglobin levels as both a therapeutic target and predictor of outcome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004891","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T16:40:26Z","timestamp":1614357626000},"page":"828-837","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":48,"title":["Admission Hemoglobin Levels Are Associated With Functional Outcome in Spontaneous Intracerebral Hemorrhage"],"prefix":"10.1097","volume":"49","author":[{"given":"Juli\u00e1n N.","family":"Acosta","sequence":"first","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey C.","family":"Leasure","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R.","family":"Kuohn","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron P.","family":"Both","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils H.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT."},{"name":"Division of Vascular Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren H.","family":"Sansing","sequence":"additional","affiliation":[{"name":"Division of Vascular Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Matouk","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery, Department of Neurosurgery, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Testai","sequence":"additional","affiliation":[{"name":"Vascular Neurology, Department of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Langefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Kamel","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care, Department of Neurology, Weill Cornell Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh B.","family":"Murthy","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care, Department of Neurology, Weill Cornell Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri, Columbia, MO."},{"name":"Zeenat Qureshi Stroke Institute, St. Cloud, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"Mayer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Henry Ford Hospital, Detroit, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Sheth","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido J.","family":"Falcone","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.2019.2413","article-title":"Cerebral intraparenchymal hemorrhage: A review.","volume":"321","author":"Gross","year":"2019","journal-title":"JAMA"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(18)31878-6","article-title":"Intracerebral haemorrhage: Current approaches to acute management.","volume":"392","author":"Cordonnier","year":"2018","journal-title":"Lancet"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.drudis.2012.06.015","article-title":"Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases.","volume":"17","author":"Mei","year":"2012","journal-title":"Drug Discov Today"},{"issue":"7 PART 2","key":"R4-20250502","first-page":"51S","article-title":"Drug repurposing for drug development in stroke.","volume":"30","author":"Fagan","year":"2010","journal-title":"Pharmacotherapy"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/VHRM.S140951","article-title":"Anemia and acute coronary syndrome: Current perspectives.","volume":"14","author":"Stucchi","year":"2018","journal-title":"Vasc Health Risk Manag"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jcrc.2013.11.008","article-title":"The impact of low hemoglobin levels and transfusion on critical care patients with severe ischemic stroke: STroke: RelevAnt Impact of HemoGlobin, Hematocrit and Transfusion (STRAIGHT)\u2013an observational study.","volume":"29","author":"Kellert","year":"2014","journal-title":"J Crit Care"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/2193-1801-2-379","article-title":"Nadir hemoglobin is associated with poor outcome from intracerebral hemorrhage.","volume":"2","author":"Chang","year":"2013","journal-title":"Springerplus"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc8961","article-title":"Low hemoglobin is associated with poor functional outcome after non-traumatic, supratentorial intracerebral hemorrhage.","volume":"14","author":"Diedler","year":"2010","journal-title":"Crit Care"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.115.003019","article-title":"Impact of hemoglobin levels and anemia on mortality in acute stroke: Analysis of UK regional registry data, systematic review, and meta-analysis.","volume":"5","author":"Barlas","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1212\/WNL.0000000000007820","article-title":"Low hemoglobin and hematoma expansion after intracerebral hemorrhage.","volume":"93","author":"Roh","year":"2019","journal-title":"Neurology"},{"key":"R11-20250502","first-page":"1","article-title":"Anemia increases the mortality risk in patients with stroke: A meta-analysis of cohort studies.","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/cc12827","article-title":"Anemia is an independent prognostic factor in intracerebral hemorrhage: An observational cohort study.","volume":"17","author":"Kuramatsu","year":"2013","journal-title":"Crit Care"},{"key":"R13-20250502","first-page":"1","article-title":"Associations of anemia with outcomes in patients with spontaneous intracerebral hemorrhage: A meta-analysis.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Neurol"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.020","article-title":"Anemia on admission increases the risk of mortality at 6 months and 1 year in hemorrhagic stroke patients in China.","volume":"23","author":"Zeng","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1747-4949.2012.00951.x","article-title":"Anaemia on admission is associated with more severe intracerebral haemorrhage and worse outcomes.","volume":"10","author":"Bussi\u00e8re","year":"2015","journal-title":"Int J Stroke"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/CCM.0b013e31819ced3a","article-title":"Anemia and hematoma volume in acute intracerebral hemorrhage.","volume":"37","author":"Kumar","year":"2009","journal-title":"Crit Care Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/cc7916","article-title":"Anemia and red blood cell transfusion in neurocritical care.","volume":"13","author":"Kramer","year":"2009","journal-title":"Crit Care"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(82)90050-2","article-title":"Uraemic bleeding: Role of anaemia and beneficial effect of red cell transfusions.","volume":"2","author":"Livio","year":"1982","journal-title":"Lancet"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1537-2995.2010.02586.x","article-title":"Effects of red blood cells on hemostasis.","volume":"50","author":"Roeloffzen","year":"2010","journal-title":"Transfusion"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1212\/WNL.0b013e3182143317","article-title":"Defining hematoma expansion in intracerebral hemorrhage: Relationship with patient outcomes.","volume":"76","author":"Dowlatshahi","year":"2011","journal-title":"Neurology"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in cerebral hemorrhage.","volume":"375","author":"Qureshi","year":"2016","journal-title":"N Engl J Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.","volume":"358","author":"Mayer","year":"2008","journal-title":"N Engl J Med"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1161\/STROKEAHA.113.002332","article-title":"The ethnic\/racial variations of intracerebral hemorrhage (ERICH) study protocol.","volume":"44","author":"Woo","year":"2013","journal-title":"Stroke"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"e1001855","DOI":"10.1371\/journal.pmed.1001855","article-title":"Individual participant data (IPD) meta-analyses of randomised controlled trials: Guidance on their use.","volume":"12","author":"Tierney","year":"2015","journal-title":"PLoS Med"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/STROKEAHA.117.017866","article-title":"Evolution of the modified Rankin scale and its use in future stroke trials.","volume":"48","author":"Broderick","year":"2017","journal-title":"Stroke"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/jamaneurol.2013.98","article-title":"Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage.","volume":"70","author":"Falcone","year":"2013","journal-title":"JAMA Neurol"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/01.STR.20.6.828","article-title":"Interobserver agreement for the assessment of handicap in stroke patients.","volume":"20","author":"Bamford","year":"1989","journal-title":"Stroke"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1227\/NEU.0b013e31820cccb2","article-title":"Packed red blood cell transfusion and decreased mortality in intracerebral hemorrhage.","volume":"68","author":"Sheth","year":"2011","journal-title":"Neurosurgery"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"105317","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105317","article-title":"Red blood cell transfusions and outcomes after intracerebral hemorrhage.","volume":"29","author":"Roh","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:16:31Z","timestamp":1746206191000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004891","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}